Cargando…
Prevalence and healthcare burden of pulmonary alveolar proteinosis
Pulmonary alveolar proteinosis (PAP) is a rare syndrome of alveolar surfactant accumulation, resulting hypoxemic respiratory failure, and increased infection risk. Despite advances in our understanding of disease pathogenesis and the availability of improved diagnostics, the epidemiology and healthc...
Autores principales: | McCarthy, Cormac, Avetisyan, Ruzan, Carey, Brenna C., Chalk, Claudia, Trapnell, Bruce C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069872/ https://www.ncbi.nlm.nih.gov/pubmed/30064481 http://dx.doi.org/10.1186/s13023-018-0846-y |
Ejemplares similares
-
The Alveolar Lipidome in Pulmonary Alveolar Proteinosis. A New Target for Therapeutic Development?
por: Trapnell, Bruce C., et al.
Publicado: (2019) -
Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018) -
Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association
por: Anderson, Kirsten, et al.
Publicado: (2019) -
The parallel lives of alpha(1)-antitrypsin deficiency and pulmonary alveolar proteinosis
por: Trapnell, Bruce C, et al.
Publicado: (2013) -
Assessment and management of pulmonary alveolar proteinosis in a reference center
por: Campo, Ilaria, et al.
Publicado: (2013)